← Issue №14/ week of Oct 4, 2026/Hepatology

An Automated Microfluidic System for Haemostasis Assessment in Cirrhosis With Thrombocytopenia.

From GI Signals issue №14: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Hepatology prospective cohort · n=81 · Oct 1, 2026 · Liver International · IF 6.7

An Automated Microfluidic System for Haemostasis Assessment in Cirrhosis With Thrombocytopenia.

Basic sciencecirrhosisbiomarkertranslationalartificial intelligence
Clinical takeawayNo clinical action yet: further validation is needed before clinical use.
What it foundT-TAS showed high reproducibility (intraclass correlation coefficients ≈0.90) and reduced thrombus formation with worsening cirrhosis severity and bacterial infection (p < 0.05) compared to conventional lab tests.
ContextChallenges current practice by offering a reproducible alternative to conventional lab tests for assessing bleeding risk in cirrhosis patients with thrombocytopenia, which currently lack precision.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Bitto N … La Mura V · Liver International : Official Journal of the International Association for the Study of the Liver · IF 6.7 · PubMed ↗Permalink
← Read the whole of issue №14 Every paper GI Signals surfaces gets a page like this one. All issues